PDL BioPharma (PDLI): Q1 EPS of $0.29 beats by $0.02. Revenue of $77.3M (-7.2% Y/Y) in-line. (PR)

|About: PDL BioPharma, Inc. (PDLI)|By:, SA News Editor
PDL BioPharma (PDLI): Q1 EPS of $0.29 beats by $0.02. Revenue of $77.3M (-7.2% Y/Y) in-line. (PR)